Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

AstraZeneca: Company contact - Saxa/dapa’s CRL remains unclear

BUY, Fair Value  5100p (+23%)

Published last October Monday 19, 2015

Carrefour postview: concerns on China and financial services but guidance maintained

BUY, Fair Value EUR31 (+7%)

Published last October Monday 19, 2015

What to retain from latest news on EDF?

BUY, Fair Value EUR21 (+20%)

Published last October Monday 19, 2015

Danone: Solid sales trend in Q3

BUY, Fair Value EUR71 (+22%)

Published last October Monday 19, 2015

Rémy Cointreau: Better H2 is expected

BUY, Fair Value EUR72 (+20%)

Published last October Monday 19, 2015
Keolis announces its strategic partnership with Masabi

Keolis announces its strategic partnership with Masabi

Published last October Thursday 15, 2015

Toward a greener Engie

BUY, Fair Value EUR21 (+40%)

Published last October Thursday 15, 2015

Galapagos: Triple combination advances, positive read-across (LLY/ROG)

BUY, Fair Value EUR52 (+30%)

Published last October Thursday 15, 2015

Casino Q3 2015 sales (first take): 1/ indisputably strong in France; 2/ concerns in Thaïland

BUY, Fair Value EUR69 (+29%)

Published last October Thursday 15, 2015

Bayer: It's not good news if Syngenta is representative of the situation in Crop markets in Q3

NEUTRAL, Fair Value EUR124 (+15%)

Published last October Thursday 15, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities